PROM1 and esophageal squamous cell carcinoma: Nakajima et al.[38] reported that CD133 expression in resected ESCC specimens following neoadjuvant chemoradiotherapy tended to be correlated with poor prognosis, but multivariate analysis did not produce a significant correlation.